Research Insight
Novartis drug Afinitor® reduces seizures patients with tuberous sclerosis complex
Novartis announced results from a Phase III study showing Afinitor®* (everolimus), when used as an adjunctive therapy, significantly reduced treatment-resistant seizures associated with tuberous...
Research Insight
The use of Surgical Patch TachoSil (human thrombin/human fibrogen) in Neurological Surgerye is approved by European Commission.
Takeda Pharmaceutical Company Limited announced that the European Commission has granted an expanded indication for surgical patch TachoSil (human thrombin/human fibrogen) for use in...
Research Insight
Bristol-Myers Squibb’s Opdivo Receives Breakthrough Therapy Designation from US FDA for Previously Treated Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
Designation based on results of Phase 3 study, CheckMate -141, in which Opdivo met its primary endpoint of overall survival, versus three standard of...
Press Releases
Biogen Appoints Michael Ehlers Executive Vice President, Research and Development
Biogen announced the appointment of Michael Ehlers, M.D., Ph.D., as executive vice president, Research and Development. World pharma today/Press releases /-Dr....
Press Releases
Sunovion Pharmaceuticals Inc reports Two Phase 3 Clinical Studies for People with Moderate-to-Very Severe Chronic Obstructive Pulmonary Evaluating SUN-101/eFlow (glycopyrrolate)
The GOLDEN-3 and GOLDEN-4 Phase 3 trials evaluating SUN-101/eFlow® in people with moderate-to-very severe COPD met their primary endpoint with a statistically significant change...
Industry Reports
Baxter Provides Updated Financial Outlook for 2016
Positive Sales Mix and Disciplined Expense Management Contribute to Strong First Quarter Performance; Adjusted Earnings Per Share were $0.36; First-quarter GAAP Earnings Per Share...
News
Mallinckrodt to Present at UBS Global Healthcare Conference
Mallinckrodt Pharmaceuticals a leading global specialty biopharmaceutical company, will present on Tuesday, May 24, 2016, at the UBS Global Healthcare Conference at the Grand...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read